Go behind the scenes of the Cancer Calculus investigation, and hear insights about Merck's cancer drug Keytruda from ICIJ's chief reporter and a health economist.
This is an ingested summary. Full reporting is available at the primary source below.
Severity: 3.1/10Source: ICIJ (International Consortium of Investigative Journalists)